Heritas Venture Fund
VC Fund
Singapore, Singapore
Heritas Venture Fund is a Singapore-based venture capital fund.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Heritas Venture Fund invests in
Stages Heritas Venture Fund invests in
Countries Heritas Venture Fund invests in
Investment Focus
Industry
- Health Care 2 (67%)
- Information Technology 2 (67%)
- Travel 1 (33%)
- Fitness 1 (33%)
- Leisure 1 (33%)
Stage
- Series B 1 (33%)
- Series C 1 (33%)
- Private Equity 1 (33%)
Country
- India 1 (33%)
- Singapore 1 (33%)
- Bangladesh 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Shohoz
|
Shohoz.com, owned and operated by Shohoj Limited, is a premium online travel service provider which aims to make long distance travel in Bangladesh easy and convenient. Driven by the passion to serve you better, Shohoz.com went on to pioneer the online travel industry by offering bus tickets and launch tickets. In entertainment sector, movietickets, event tickets as well as cricket match tickets are also available on Shohoz.com. Their team of energetic and young professionals with deep expertise in eCommerce and travel domains, leave no stone unturned to provide you the best of services at minimal costs through their user friendly website, Android App, Partner network all over Bangladesh and a multi-lingual call center. | Series B / Mar 19, 2019 | |
CXA Group
|
From a modest start in 2013, when they had just three Fortune 500 clients, CXA has grown to become Asia’s leading Insurtech start-up - affirmed by over 600 clients and backed by a group of astute investors who understand the value and transformative potential of CXA’s groundbreaking platform.Employees are now able to proactively manage theirhealth by choosing the best-suited insurance, wellness and disease management offerings while employers are able to view aggregated health and claims analytics of their workforce to prioritise interventions that reduce costs and improve workplace health, productivity and employee engagement. | $25M / Series C / Mar 13, 2019 | |
Strand Life Sciences
|
Strand Life Sciences provides bioinformatics solutions with advanced visualization, predictive systems modeling, data integration, and scientific context management components to transform raw data into actionable insights. The company employs 200 people, mostly in Bangalore, India, and services both the research and clinical markets. Strandenjoys three advantages over the competition globally: superior software analytics, superior curation of gene variants, and a major cost advantage for DNA test interpretation. When combined, Strand is finding a rapidly growing demand for its StrandOmics software platform, which hospitals and service providers can use to service their patients and healthcare clients. With every sequence and gene test, the company’s cloud database gets more valuable with related metadata, which can be used to improve future analytics, thereby creating an additional demand for StrandOmics.Strand has developed the most advanced software for analyzing DNA sequences. Today, 1,400 research institutions worldwide use Strand’s software under the product names GeneSpring (marketed by Agilent) and Avadis (marketed by Strand). The company reached profitability in 2007, and in early 2013, the company began to service the clinical market in India. It opened its own DNA sequence and gene panel wet lab in Bangalore, India, and in December, the company opened a lab which it operates in the 1,400-bed Mazumdar-Shaw Cancer Center in Bangalore. By the end of 2013, Strand was servicing the gene testing and DNA sequence analysis needs of over 100 hospitals in India, and in 2014 it has begun to expand into the US market. | $13M / Private Equity / Feb 08, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Heritas Venture Fund invest in?
Heritas Venture Fund invests primarily in Health Care, Information Technology and Travel startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Heritas Venture Fund last invest?
The most recent investment recorded for Heritas Venture Fund closed in Mar 2019. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
